AOP Orphan Pharmaceuticals Aktiengesellschaft
Contact:
AOP
Phone: +43 503 72 44-24
E-Mail: olena.weissenbacher@aoporphan.com
Contact:
AOP
Phone: +43 503 72 44-24
E-Mail: olena.weissenbacher@aoporphan.com
KEYWORDS:
- Jean-Guillaume Lecomte
- AOP's neurology focus
- Dr. Georg Fischer, AOP
- narcolepsy
- Dr. Rudolf Widmann
- European Medicines Agency (EMA)
- Wakix®
- Bioprojet Pharma SAS
- Wakix® (pitolisant)
- AOP ORPHAN
attachments to announcement
AOP Orphan and Bioprojet Pharma SAS entered a distribution agreement for Wakix®
back to announcementphotos
 [ download press photo ] | title: AOP Orphan Pharmaceuticals AG image text: AOP Orphan will distribute Wakix® (pitolisant) from Bioprojet Pharma SAS in Austria, Nordic countries and Central Eastern Europe. copyright: AOP Orphan |
